| Sr. No | Title of the project | Funding agency | Duration | Name of PI / Co-PI | Status |
|---|---|---|---|---|---|
| 1 | Studies on structural, functional and evolutionary aspects of repair proteins with special relevance to human disease | DST | 3 Years (2012-2015) | Dr. Tiratha Raj Singh | Completed |
| 2 | Identification of Single Nucleotide Polymorphisms in the transcriptional regulatory region of autophagy gene, ULK1 and their role in susceptibility to chronic hepatitis B virus infection | DBT | 3 Years (2013-2016) | Dr. Harish Changotra / Dr. Jitendraa Vashishtt | Completed |
| 3 | Autophagy genes (Atg16L1 and IRGM) single nucleotide polymorphisms in the susceptibility of chronic hepatitis B virus infection | DST | 3 Years (2013-2016) | Dr. Harish Changotra | Completed |
| 4 | Identification, characterization of diarrhoeagenic pathogens in Himachal Pradesh | ICMR | 3 Years (2013-2016) | Dr. Jitendraa Vashishtt / Dr. Harish Changotra, Dr. Rahul Shrivastava | Completed |
| 5 | Development, characterization & processing of quantum dots for imaging in near infrared (NIR) range | DST | 3 Years (2014-2018) | Dr. Ragini Raj Singh | Completed |
| 6 | A Bioinformatic and experimental approach to investigate the interaction between acetylcholinesterase (AchE) and angiotensin-converting-enzyme (ACE) along with Alzheimer’s Disease associated proteins | ICMR | 3 Years (2015-2018) | Dr. Tiratha Raj Singh / Dr. M. Udaibanu | Completed |
| 7 | Identification of biofilm associated proteins of multidrug resistant Acinetobacter baumannii as potential drug target and inhibitors thereof | DST | 3 Years (2015-2018) | Dr. Jitendraa Vashishtt | Completed |
| 8 | Role of plasma level of soluble receptor for advanced glycation end-products (sRAGE) in COPD patients-a hospital-based case control study | ICMR-IGMC | 2 Years (2017-2019) | Dr. Malya Sarkar / Dr. Harish Changotra | Completed |
| 9 | Identification, inhibition mechanism analysis and validation of novel multitarget inhibitors for Alzheimer’s disease using polypharmacology and Systems pharmacology approaches | ICMR | 3 Years (2019-2022) | Dr. Tiratha Raj Singh | Ongoing |
